跳至主要内容
临床试验/NCT02594358
NCT02594358撤回1 期

Caffeine in Amblyopia Study

Johns Hopkins University1 个研究点 分布在 1 个国家开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
试验地点
1
主要终点
Visual acuity

研究概览

简要总结

Prospective data on the visual acuity response in children treated by patching concurrently treated with caffeine and estimate the magnitude of effect that might be seen in a randomized trial (if no improvement in acuity is seen, this would be sufficient evidence to decide not to conduct a randomized, double blind trial).

Collect prospective data on the tolerability of caffeine in two dosages as an adjuvant treatment for amblyopia and provide limited data on its safety.

Evaluate the potential for a dietary intervention to enhance the acceptance and tolerability of patching on the child and family.

Demonstrate recruitment potential of subjects to participate in a dietary intervention study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
7 Years 至 13 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Amblyopia from strabismus and amblyopia

排除标准

  • •Known intolerance to caffeine
  • •Diagnosis and/or treatment of attention deficit/hyperactivity disorder
  • •Presence of an ocular cause for reduced visual acuity
  • •Myopia with a special equivalent -6.00 diopters
  • •Current vision therapy or orthoptics - any type
  • •Ocular cause for reduced visual acuity
  • •Prior intraocular or refractive surgery
  • •History of narrow-angle glaucoma
  • •Strabismus surgery planned within 16 weeks
  • •Nystagmus per se does not exclude the subject if the above visual acuity criteria are met
  • •Known skin reactions to patch or bandage adhesives
  • •Known allergy or intolerance to food dyes
  • •Current treatment with topical atropine eyedrops
  • •Menarche, pregnancy or lactation
  • •Use of any of the following medications which may affect caffeine metabolism: nafcillin, verapamil, fluvoxamine, ciprofloxacin and other fluoroquinolones, modafinil, nafcillin, and omeprazole

研究组 & 干预措施

Caffeine 40 mg

Active Comparator

Patching plus once daily caffeine for 12 weeks

干预措施: Caffeine (Drug)

Caffeine 20 mg

Active Comparator

Patching plus once daily caffeine for 12 weeks

干预措施: Caffeine (Drug)

结局指标

主要结局

Visual acuity

时间窗: 12 weeks

Quantitative improvement in high resolution visual acuity measured at 3 meters

次要结局

  • Questionnaire(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Repka

Professor of Ophthalmology

Johns Hopkins University

研究点 (1)

Loading locations...

相似试验